Inder Kaul is the founder of Draig Therapeutics. Draig Therapeutics has raised $140M in total funding. Latest round: Series A.
Inder Kaul serves as the Chief Medical Officer at Draig Therapeutics, a Cardiff University spin-out focused on developing therapies for neuropsychiatric disorders. The company secured £107 million ($140 million) in funding from investors like Access Biotechnology, SV Health Investors, and ICG. Draig Therapeutics is advancing a clinical-stage candidate, DT-101, for major depressive disorder and has additional programs targeting GABAA receptor modulators. Previously, Kaul held positions at Bristol-Myers Squibb and Karuna Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library